Senate Finance Committee Holds Hearing On Rising Drug Prices - Tuesday, April 9 2019

Executives from five of the health care industry's top pharmacy benefit management companies are set to testify Tuesday at a hearing on the rising cost of drug prices in the U.S. before the Senate Finance Committee.
Chairman Chuck Grassley, R-Iowa, and the panel's top Democrat Sen. Ron Wyden, D-Ore., are expected to grill pharmacy benefit managers, or PBMs, on the role they play in increasing drug prices.
Those who will testify include:
• CVS Health Executive Vice President Derica Rice
• OptumRx CEO John Prince
• Cigna Chief Clinical Officer Dr. Steve Miller
• Prime Therapeutics interim President Mike Kolar
• Humana President of health care services William Fleming
» Subscribe to CNBC: cnb.cx/Subscrib...
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get the latest news: www.cnbc.com/
Receive exclusive commentary from CNBC anchor Kelly Evans: www.cnbc.com/t...
Find CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Google+: cnb.cx/PlusCNBC
Follow CNBC News on Instagram: cnb.cx/Instagra...
WATCH LIVE: Senate Finance Committee holds hearing on rising drug prices - Tuesday, April 9 2019

[@gzakaria1]

Full transparency must be mandatory. Paying less than cost at pharmacy (not PBM owned) and charging insurance way higher price (over 90%), is PBM's business.

[@gzakaria1]

Pharmacists' professional fee mostly nothing, or less than 80 cents.

[@gzakaria1]

Express scripts pays just for pills or less not for vials, labels, caps and pharmacist's professional fee.

[@teebone2157]

These are all for show. THey never take action

[@delprice3007]

PBM BS